https://onco-news.kirilow.workers.dev/https://onco-news.kirilow.workers.dev/archivehttps://onco-news.kirilow.workers.dev/authors/editorial-teamhttps://onco-news.kirilow.workers.dev/editorial-policyhttps://onco-news.kirilow.workers.dev/category/regulatoryhttps://onco-news.kirilow.workers.dev/category/new-medicineshttps://onco-news.kirilow.workers.dev/category/clinical-trialshttps://onco-news.kirilow.workers.dev/news/tedopi-combi-ted-phase2-nsclc2026-10-20T06:08:20.000Zhttps://onco-news.kirilow.workers.dev/news/divarasib-krascendo1-phase3-nsclc2026-10-20T06:08:20.000Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-jemperli-dmmr-msih-rak-rektum2026-10-20T06:08:20.000Zhttps://onco-news.kirilow.workers.dev/news/merck-silence-therapeutics-divesiran-pv2026-10-20T06:08:20.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-talvey-daratumumab-monumental3-myeloma2026-10-20T06:08:20.000Zhttps://onco-news.kirilow.workers.dev/news/neoadyuvantna-sabr-ivc-tromb-rcc2026-10-16T06:01:15.000Zhttps://onco-news.kirilow.workers.dev/news/neonipiga-dalgosrochen-msih-rak-stomah2026-10-16T06:01:15.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-rasonque-daraxonrasib-rak-pankreas2026-10-16T06:01:15.000Zhttps://onco-news.kirilow.workers.dev/news/vs7375-target-d-kras-g12d-pankreas2026-10-15T06:05:25.000Zhttps://onco-news.kirilow.workers.dev/news/ponatinib-blinatumomab-phase3-ph-all2026-10-16T06:01:15.000Zhttps://onco-news.kirilow.workers.dev/news/fda-anktiva-papilaren-nmibc2026-10-16T06:01:15.000Zhttps://onco-news.kirilow.workers.dev/news/bnt113-ahead-merit-neuspeshna-parva-krajna-tochka2026-10-14T06:02:12.000Zhttps://onco-news.kirilow.workers.dev/news/fda-prie-fyb206-biosimilar-pembrolizumab2026-10-14T06:02:12.000Zhttps://onco-news.kirilow.workers.dev/news/ryz101-action1-gep-net-pfs2026-10-13T06:07:34.000Zhttps://onco-news.kirilow.workers.dev/news/prgis-hrd-prostata-klinichna-validatziya2026-10-09T06:03:32.000Zhttps://onco-news.kirilow.workers.dev/news/iberdomide-excaliber-rrmm-pfs-42-mesetza2026-10-12T06:05:33.000Zhttps://onco-news.kirilow.workers.dev/news/cln049-registratzionno-phase2-aml2026-10-09T06:03:32.000Zhttps://onco-news.kirilow.workers.dev/news/psv359-fast-track-fap-sft2026-10-09T06:03:32.000Zhttps://onco-news.kirilow.workers.dev/news/guardant360-cdx-evropa-camizestrant-esr12026-10-13T06:07:34.000Zhttps://onco-news.kirilow.workers.dev/news/vir5500-fast-track-mcrpc-phase32026-10-09T06:03:32.000Zhttps://onco-news.kirilow.workers.dev/news/fda-atezolizumab-adjuvantno-dmmr-kolon2026-10-09T06:03:32.000Zhttps://onco-news.kirilow.workers.dev/news/nrg-br002-ablatziya-ne-podobryava-prezhivyaemost2026-10-08T06:02:10.000Zhttps://onco-news.kirilow.workers.dev/news/sad-sprya-keytruda-sc-osem-evropeyski-pazara2026-10-08T06:02:10.000Zhttps://onco-news.kirilow.workers.dev/news/orca-t-parvo-targovsko-prilozhenie2026-10-10T05:59:04.000Zhttps://onco-news.kirilow.workers.dev/news/fda-temab-a-breakthrough-crc-nsclc2026-10-08T06:02:10.000Zhttps://onco-news.kirilow.workers.dev/news/fda-tucatinib-poddarzhane-her2-rak-garda2026-10-08T06:02:10.000Zhttps://onco-news.kirilow.workers.dev/news/pixclara-fet-pet-start-klinichna-upotreba2026-10-07T06:08:57.000Zhttps://onco-news.kirilow.workers.dev/news/firmonertinib-furvent-ne-postigna-pfs2026-10-07T06:08:57.000Zhttps://onco-news.kirilow.workers.dev/news/epcoritamab-rchop-phase3-parva-liniya-dlbcl2026-10-12T06:05:33.000Zhttps://onco-news.kirilow.workers.dev/news/epcoritamab-r-chop-epcore-dlbcl2-pfs2026-10-06T06:00:27.000Zhttps://onco-news.kirilow.workers.dev/news/rasolute309-daraxonrasib-zoldonrasib-phase32026-10-06T06:00:27.000Zhttps://onco-news.kirilow.workers.dev/news/ge-healthcare-sofie-fapi74-pet-onkologia2026-10-06T06:00:27.000Zhttps://onco-news.kirilow.workers.dev/news/aft70-navigate-mrd-nasocheno-lechenie-rak-garda2026-10-15T06:05:25.000Zhttps://onco-news.kirilow.workers.dev/news/rinatabart-sesutecan-rainfol01-ovarian2026-10-06T06:00:27.000Zhttps://onco-news.kirilow.workers.dev/news/cusp06-cdh6-adc-otgovor-yaychnik2026-10-07T06:08:57.000Zhttps://onco-news.kirilow.workers.dev/news/datroway-ivonescimab-klinichno-partniorstvo2026-10-03T06:01:02.000Zhttps://onco-news.kirilow.workers.dev/news/datroway-ivonescimab-klinichna-kombinatsiya2026-10-13T06:07:34.000Zhttps://onco-news.kirilow.workers.dev/news/fda-pirtobrutinib-parva-liniya-cll-sll2026-10-06T06:00:27.000Zhttps://onco-news.kirilow.workers.dev/news/fda-rtor-zipalertinib-parva-liniya-egfr-exon202026-10-02T05:59:20.000Zhttps://onco-news.kirilow.workers.dev/news/foghorn-lilly-prekratiha-fhd9092026-10-03T06:01:02.000Zhttps://onco-news.kirilow.workers.dev/news/ubamatamab-muc16-lgsoc-otgovor2026-10-02T05:59:20.000Zhttps://onco-news.kirilow.workers.dev/news/japan-odobri-optune-pax-rak-pankreas2026-10-07T06:08:57.000Zhttps://onco-news.kirilow.workers.dev/news/fda-rtor-zipalertinib-egfr-exon20-nsclc2026-10-11T06:00:11.000Zhttps://onco-news.kirilow.workers.dev/news/decipher-predskazva-polza-adt-lacheterapiya-prostata2026-10-04T06:05:22.000Zhttps://onco-news.kirilow.workers.dev/news/azacitidine-cedazuridine-aztound-phase32026-10-02T05:59:20.000Zhttps://onco-news.kirilow.workers.dev/news/chn-hypopmrt-desetgodishni-rezultati2026-10-11T06:00:11.000Zhttps://onco-news.kirilow.workers.dev/news/giredestrant-everolimus-evera-esr1-pfs2026-10-12T06:05:33.000Zhttps://onco-news.kirilow.workers.dev/news/giredestrant-everolimus-evera-pfs2026-10-02T05:59:20.000Zhttps://onco-news.kirilow.workers.dev/news/yaponiya-odobri-optune-pax-pankreas2026-10-02T05:59:20.000Zhttps://onco-news.kirilow.workers.dev/news/astx030-aztound-phase3-mds-cmml2026-10-14T06:02:12.000Zhttps://onco-news.kirilow.workers.dev/news/aglatimagene-imunno-remodelirane-prostata-phase32026-10-04T06:05:22.000Zhttps://onco-news.kirilow.workers.dev/news/soft-preop-sbrt-rak-pankreas2026-10-01T05:58:15.000Zhttps://onco-news.kirilow.workers.dev/news/mdt-bridge-durvalumab-neoperabilen-nsclc2026-10-01T05:58:15.000Zhttps://onco-news.kirilow.workers.dev/news/sbrt-sreshtu-rfa-malak-hcc2026-09-30T06:08:56.000Zhttps://onco-news.kirilow.workers.dev/news/fda-zayavlenie-orpathys-tagrisso-savanna2026-09-29T06:56:06.000Zhttps://onco-news.kirilow.workers.dev/news/astrazeneca-summit-ivonescimab-adc-partniorstvo2026-09-29T06:41:48.000Zhttps://onco-news.kirilow.workers.dev/news/fda-zayavlenie-savolitinib-osimertinib-met-nsclc2026-10-03T06:01:02.000Zhttps://onco-news.kirilow.workers.dev/news/nrg-gi003-protoni-fotoni-hcc2026-09-30T06:08:56.000Zhttps://onco-news.kirilow.workers.dev/news/hipofrakcionirana-lacheterapiya-sled-mastektomiya-10-godini2026-09-30T06:08:56.000Zhttps://onco-news.kirilow.workers.dev/news/merck-scibrunch-spr2015-kras-g12d2026-10-03T06:01:02.000Zhttps://onco-news.kirilow.workers.dev/news/pace-a-sbrt-sreshtu-operaciya-prostata2026-09-29T06:42:13.000Zhttps://onco-news.kirilow.workers.dev/news/a071801-frakcionirana-radiokhirurgiya-mozachni-metastazi2026-09-29T06:42:47.000Zhttps://onco-news.kirilow.workers.dev/news/nrg-cc009-srs-mozachni-metastazi-sclc2026-09-29T06:43:04.000Zhttps://onco-news.kirilow.workers.dev/news/fractionirana-srs-golemi-mozachni-metastazi2026-10-11T06:00:11.000Zhttps://onco-news.kirilow.workers.dev/news/pace-a-sbrt-spryamo-operatziya-prostata2026-10-10T05:59:04.000Zhttps://onco-news.kirilow.workers.dev/news/fda-prioriteten-pregled-elinzanetant-oasis42026-09-30T06:08:56.000Zhttps://onco-news.kirilow.workers.dev/news/i-sabr-nivolumab-6-godini-nsclc2026-09-30T06:08:56.000Zhttps://onco-news.kirilow.workers.dev/news/aews1221-sbrt-metastazi-sarkom-yuing2026-10-01T05:58:15.000Zhttps://onco-news.kirilow.workers.dev/news/nrg-gu003-hipofrakcionirana-postoperativna-lacheterapiya2026-10-01T05:58:15.000Zhttps://onco-news.kirilow.workers.dev/news/cepheus-daratumumab-dvrd-traina-mrd-polza2026-09-28T12:06:52.000Zhttps://onco-news.kirilow.workers.dev/news/iaso206-in-vivo-car-t-mielom2026-10-04T06:05:22.000Zhttps://onco-news.kirilow.workers.dev/news/perseus-daratumumab-shestgodishna-pfs-mielom2026-10-04T06:05:22.000Zhttps://onco-news.kirilow.workers.dev/news/ifinatamab-deruxtecan-otteglena-bla-sclc2026-10-13T06:07:34.000Zhttps://onco-news.kirilow.workers.dev/news/iberdomide-excaliber-rrmm-mrd-phase32026-09-27T09:34:08.000Zhttps://onco-news.kirilow.workers.dev/news/fda-prioriteten-pregled-durvalumab-enfortumab-mibc2026-09-27T09:34:38.000Zhttps://onco-news.kirilow.workers.dev/news/roam-eortc1308-radioterapiya-atipichen-meningiom2026-10-12T06:05:33.000Zhttps://onco-news.kirilow.workers.dev/news/ottegleno-zayavlenie-ifinatamab-deruxtecan-sclc2026-09-27T09:35:26.000Zhttps://onco-news.kirilow.workers.dev/news/fda-belzutifan-lenvatinib-naprednal-ccrcc2026-09-27T09:36:02.000Zhttps://onco-news.kirilow.workers.dev/news/fda-lirafugratinib-fgfr2-holangiokarcinom2026-09-27T09:36:20.000Zhttps://onco-news.kirilow.workers.dev/news/fda-sot106-fast-track-orphan-sarkom2026-09-28T12:06:36.000Zhttps://onco-news.kirilow.workers.dev/news/fda-panel-galleri-mnogotumoren-test2026-10-10T05:59:04.000Zhttps://onco-news.kirilow.workers.dev/news/fda-panel-podkrepi-galleri-mced2026-10-01T05:58:15.000Zhttps://onco-news.kirilow.workers.dev/news/fda-galleri-mnogotumoren-kraven-test2026-09-27T09:37:08.000Zhttps://onco-news.kirilow.workers.dev/news/telix-itm-radiopharma-obedinenie-lu1772026-09-22T09:16:00.000Zhttps://onco-news.kirilow.workers.dev/news/fda-inluriyo-verzenio-esr1-rak-garda2026-09-21T13:39:13.000Zhttps://onco-news.kirilow.workers.dev/news/gpc3-car-t-remisiya-hepatoblastom2026-09-21T13:38:35.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-pepaxti-po-ranna-liniya-mielom2026-09-22T09:15:32.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-tecvayli-po-ranna-liniya-mielom2026-09-21T13:38:41.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-padcev-keytruda-perioperativno-mibc2026-09-21T13:38:45.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-enhertu-adjuvantno-her2-ranen-rak-garda2026-09-21T13:39:02.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-pebrilzo-pertuzumab-biosimilar2026-09-20T06:06:26.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-sepalna-senaparib-poddarzhane-yaychnik2026-09-20T06:06:31.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-lifyorli-relacorilant-rak-yaychnik2026-09-20T06:06:37.000Zhttps://onco-news.kirilow.workers.dev/news/chmp-gevalka-ensartinib-alk-nsclc2026-09-20T06:06:46.000Zhttps://onco-news.kirilow.workers.dev/news/nhs-england-enhertu-her2-low-dostap2026-09-20T06:06:20.000Zhttps://onco-news.kirilow.workers.dev/news/fda-prie-bezuclastinib-advsm2026-09-16T09:35:04.000Zhttps://onco-news.kirilow.workers.dev/news/gsk-chimagen-trispecific-tce-mielom2026-09-16T09:32:56.000Zhttps://onco-news.kirilow.workers.dev/news/fda-tarlatamab-namaleno-nablyudenie2026-09-15T07:27:39.000Zhttps://onco-news.kirilow.workers.dev/news/fda-bexlutry-lu177-gep-net2026-09-15T06:24:11.000Zhttps://onco-news.kirilow.workers.dev/news/fda-ameluz-pdt-bazocelularen-karcinom2026-09-15T07:27:35.000Zhttps://onco-news.kirilow.workers.dev/news/fda-pixclara-fet-pet-gliom2026-09-15T07:27:52.000Zhttps://onco-news.kirilow.workers.dev/news/gotistobart-preserve-003-skvamozen-nsclc2026-09-15T07:28:04.000Zhttps://onco-news.kirilow.workers.dev/news/zidesamtinib-arros-1-ros1-parva-liniya2026-09-16T09:35:32.000Zhttps://onco-news.kirilow.workers.dev/news/trastuzumab-deruxtecan-destiny-lung04-pfs2026-09-17T19:20:53.000Zhttps://onco-news.kirilow.workers.dev/news/osimertinib-adaura-osem-godini-os2026-09-16T09:35:19.000Zhttps://onco-news.kirilow.workers.dev/news/amivantamab-papillon-finalna-os2026-09-16T09:35:12.000Zhttps://onco-news.kirilow.workers.dev/news/evoke03-sacituzumab-pembrolizumab-neuspeh2026-09-16T09:34:36.000Zhttps://onco-news.kirilow.workers.dev/news/maverick-mri-bez-pci-sclc2026-09-16T09:34:43.000Zhttps://onco-news.kirilow.workers.dev/news/zipalertinib-rezilient3-egfr-exon20-pfs2026-09-16T09:34:54.000Zhttps://onco-news.kirilow.workers.dev/news/tam-peli-taishan-302-sclc-os2026-09-15T07:28:24.000Zhttps://onco-news.kirilow.workers.dev/news/fda-otlaga-zanzalintinib-atezolizumab-mcrc2026-10-13T06:07:34.000Zhttps://onco-news.kirilow.workers.dev/news/fda-udalzhi-pregleda-zanzalintinib-atezolizumab2026-09-12T07:09:50.260Zhttps://onco-news.kirilow.workers.dev/news/camizestrant-serena-4-ne-postigna-pfs2026-09-12T07:09:38.239Zhttps://onco-news.kirilow.workers.dev/news/fda-sevabertinib-parva-liniya-her2-nsclc2026-09-11T06:22:49.352Zhttps://onco-news.kirilow.workers.dev/news/dabogratinib-smeseni-rezultati-nmibc2026-09-10T06:06:43.829Zhttps://onco-news.kirilow.workers.dev/news/ctdna-azenosertib-rak-yaychnik2026-09-11T06:23:01.857Zhttps://onco-news.kirilow.workers.dev/news/star-trec-organosohranyavashto-rektalen-rak2026-09-11T06:23:10.245Zhttps://onco-news.kirilow.workers.dev/news/tarlatamab-durvalumab-dellphi-305-os2026-09-12T07:10:02.681Zhttps://onco-news.kirilow.workers.dev/news/arlo-cel-quintessential-mnozhestven-mielom2026-09-17T19:21:15.000Zhttps://onco-news.kirilow.workers.dev/news/fda-camizestrant-esr1-serena-62026-09-11T06:23:20.550Zhttps://onco-news.kirilow.workers.dev/news/medgenome-oncotrack-mrd-ctdna2026-09-11T06:23:32.087Zhttps://onco-news.kirilow.workers.dev/news/fda-ace723-dual-payload-adc-hcc2026-09-06T07:20:24.134Zhttps://onco-news.kirilow.workers.dev/news/fda-camizestrant-esr1-rak-na-gardata2026-09-06T07:20:45.288Zhttps://onco-news.kirilow.workers.dev/news/medilink-yl201-phase-iii-pankreas2026-09-09T06:33:02.214Zhttps://onco-news.kirilow.workers.dev/news/hamlet-alpha1h-phase-iii-nmibc-chehia2026-09-09T06:33:29.385Zhttps://onco-news.kirilow.workers.dev/news/db-guide-phase-iiib-her2-hr-rak-na-gardata2026-09-06T07:21:19.695Zhttps://onco-news.kirilow.workers.dev/news/cspc-hb1801-phase-iii-her2-negativen-rak-na-gardata2026-09-09T06:33:17.129Zhttps://onco-news.kirilow.workers.dev/news/cipla-qilu-ql2107-pembrolizumab-biosimilar2026-09-04T06:06:57.771Zhttps://onco-news.kirilow.workers.dev/news/etentamig-cervino-phase-iii-mnozhestven-mielom2026-09-04T06:07:35.807Zhttps://onco-news.kirilow.workers.dev/news/tensive-eib-regenera-rekonstruktsia-rak-na-gardata2026-09-04T06:08:12.571Zhttps://onco-news.kirilow.workers.dev/news/gsk-hutchmed-hmpl-a830-kras-egfr-attc2026-09-03T09:40:08.013Zhttps://onco-news.kirilow.workers.dev/news/rationale306-tislelizumab-tri-godini-escc2026-09-06T07:23:37.274Zhttps://onco-news.kirilow.workers.dev/news/gsk-risvutatug-rezetecan-phase-iii-mcrpc2026-09-09T06:33:44.721Zhttps://onco-news.kirilow.workers.dev/news/ivonescimab-harmoni2-os-pdl1-nsclc2026-09-03T09:41:11.549Zhttps://onco-news.kirilow.workers.dev/news/tscan-sprya-phase-iii-alloha2-tsc1012026-09-03T09:41:25.869Zhttps://onco-news.kirilow.workers.dev/news/liveration-namodenoson-hcc-mezhdinen-analiz2026-09-09T06:34:04.216Zhttps://onco-news.kirilow.workers.dev/news/norroy-177lu-nym032-phase-iii-mcrpc2026-09-04T06:08:34.574Zhttps://onco-news.kirilow.workers.dev/news/renovorx-tiger-pac-phase-iii-lokalen-gemcitabine2026-09-06T07:24:01.808Zhttps://onco-news.kirilow.workers.dev/news/tqb2102-phase-iii-her2-low-rak-na-gardata2026-09-03T09:41:37.204Zhttps://onco-news.kirilow.workers.dev/news/azacitidine-venetoclax-sreshtu-induktsionna-himioterapia-aml2026-09-07T06:10:28.814Zhttps://onco-news.kirilow.workers.dev/news/ivonescimab-harmoni-2-podobri-os2026-09-17T19:21:04.000Zhttps://onco-news.kirilow.workers.dev/news/telix-bipass-phase-iii-psma-pet-predi-biopsia2026-09-03T09:42:29.561Zhttps://onco-news.kirilow.workers.dev/news/fda-breakthrough-jbs003-hpv-orofaringealen-rak2026-09-02T06:11:57.923Zhttps://onco-news.kirilow.workers.dev/news/plixorafenib-forte-braf-fusion-mezhdinen-analiz2026-09-02T06:10:04.236Zhttps://onco-news.kirilow.workers.dev/news/astrazeneca-zegfrovy-globalen-licenz-egfr-exon20-nsclc2026-09-02T06:08:49.962Zhttps://onco-news.kirilow.workers.dev/news/eu-odobri-enhertu-pertuzumab-her2-metastatichen-rak-na-gardata2026-09-02T06:06:27.706Zhttps://onco-news.kirilow.workers.dev/news/penn-conformalflash-protonna-terapia-parvo-izpitvane2026-09-07T06:11:47.230Zhttps://onco-news.kirilow.workers.dev/news/tagrisso-orpathys-sanovo-phase-iii-egfr-met-nsclc2026-09-03T09:42:54.713Zhttps://onco-news.kirilow.workers.dev/news/rezatapopt-pynnacle-ovarialen-rak-nda-20272026-09-01T08:00:07.945Zhttps://onco-news.kirilow.workers.dev/news/alpha-dart-impact-pankreas-pivotal-programa2026-09-01T08:00:35.168Zhttps://onco-news.kirilow.workers.dev/news/ziihera-herizon-gea01-os-her2-gastroezofagealen-rak2026-09-01T08:00:58.601Zhttps://onco-news.kirilow.workers.dev/news/ide849-fda-phase-iii-es-sclc2026-09-01T08:01:21.641Zhttps://onco-news.kirilow.workers.dev/news/karyopharm-snda-selinexor-ruxolitinib-mielofibroza2026-09-07T06:13:08.194Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-besremi-esentsialna-trombotsitemia2026-09-07T06:12:34.012Zhttps://onco-news.kirilow.workers.dev/news/dualitybio-genentech-dupac-adc-sdelka2026-08-30T02:49:01.256Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-rusfertide-policitemia-vera2026-08-29T06:19:32.792Zhttps://onco-news.kirilow.workers.dev/news/dawn-303-incb161734-kras-g12d-rak-na-pankreasa2026-08-29T06:19:41.067Zhttps://onco-news.kirilow.workers.dev/news/biontech-prekrati-mrna-izpitvane-ctdna-kolorektalen-rak2026-08-29T06:20:03.188Zhttps://onco-news.kirilow.workers.dev/news/tissue-free-ctdna-mrd-ranen-tnbc2026-08-28T06:15:59.472Zhttps://onco-news.kirilow.workers.dev/news/formosa-eu-cta-tsy110-kadcyla-biosimilar2026-08-31T06:24:29.028Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-daraxonrasib-metastatichen-rak-na-pankreasa-12026-08-27T12:51:21.934Zhttps://onco-news.kirilow.workers.dev/news/soquelitinib-phase-iii-periferen-t-kletachen-limfom2026-08-28T06:16:08.572Zhttps://onco-news.kirilow.workers.dev/news/fda-roche-her2-companion-diagnostics-gastroezofagealen-rak2026-08-29T14:36:30.883Zhttps://onco-news.kirilow.workers.dev/news/bexar-bexmarilimab-doxorubicin-metastatichen-sarkom2026-08-29T14:36:42.360Zhttps://onco-news.kirilow.workers.dev/news/oncoinvent-radspherin-phase-ii-ovarialen-rak2026-08-29T14:37:02.414Zhttps://onco-news.kirilow.workers.dev/news/ruxotemitide-phase-iii-visokoriskov-rezektabilen-melanom2026-08-28T06:19:20.649Zhttps://onco-news.kirilow.workers.dev/news/ec-tecvayli-daratumumab-vtora-linia-mnozhestven-mielom2026-08-31T06:25:03.570Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-daraxonrasib-rasonque2026-09-10T06:07:48.704Zhttps://onco-news.kirilow.workers.dev/news/fda-rasonque-daraxonrasib-rak-pankreas2026-10-15T06:05:25.000Zhttps://onco-news.kirilow.workers.dev/news/fda-odobri-daraxonrasib-metastatichen-rak-na-pankreasa2026-08-28T06:19:29.782Zhttps://onco-news.kirilow.workers.dev/news/ivonescimab-harmoni-phase-iii-egfr-nsclc2026-08-29T14:36:52.283Zhttps://onco-news.kirilow.workers.dev/news/fda-zanidatamab-tislelizumab-her2-gastroezofagealen-adenokarcinom2026-08-28T06:19:37.126Zhttps://onco-news.kirilow.workers.dev/news/fda-prioriteten-pregled-jemperli-dmmr-msih-rak-rektum2026-08-30T02:49:17.792Zhttps://onco-news.kirilow.workers.dev/news/erapa-serenta-phase-iii-fap-nabirane2026-09-10T07:54:22.985Zhttps://onco-news.kirilow.workers.dev/news/intismeran-autogene-phase-iii-rezetsiran-melanom2026-08-29T06:20:14.473Zhttps://onco-news.kirilow.workers.dev/news/immatics-suprame-phase-iii-anzu-cel-prame-melanom2026-08-30T02:49:28.165Zhttps://onco-news.kirilow.workers.dev/news/rad101-pivotal-phase-iii-mozachni-metastazi2026-08-30T02:49:43.037Zhttps://onco-news.kirilow.workers.dev/news/tagrisso-orpathys-saffron-phase-iii-egfr-met-nsclc2026-08-29T14:37:14.187Zhttps://onco-news.kirilow.workers.dev/news/enhertu-destiny-lung04-her2-mutiral-nsclc2026-08-29T06:20:23.555Zhttps://onco-news.kirilow.workers.dev/news/astrazeneca-prekrati-evolve-lung02-volrustomig-nsclc2026-08-30T02:48:45.714Zhttps://onco-news.kirilow.workers.dev/news/fda-iberdomide-daratumumab-mnozhestven-mielom2026-08-31T06:24:47.748Zhttps://onco-news.kirilow.workers.dev/news/lacutamab-tellomak3-phase-iii-ctcl2026-09-01T08:01:45.790Zhttps://onco-news.kirilow.workers.dev/news/fda-panel-galleri-multi-cancer-early-detection2026-09-08T08:14:53.084Zhttps://onco-news.kirilow.workers.dev/news/fda-tudriqev-nivolumab-refrakteren-melanom2026-08-31T06:25:16.908Zhttps://onco-news.kirilow.workers.dev/news/kandlelit013-calderasib-phase-iii-adjuvanten-nsclc2026-08-31T06:25:31.930Z